NewAmsterdam Pharma Co. N.V. (NAMS)
Market Closed
17 Jul, 20:00
$
31. 68
+0.63
+2.029%
$
4.12B Market Cap
- P/E Ratio
- Div Yield
704,400 Volume
-1.92 Eps
$ 31.05
Previous Close 
Want to track NAMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NAMS Earnings Reports FAQ
What is the earnings per share (EPS) for NAMS?
The current EPS is -1.92.
What is the company's earnings growth rate?
NewAmsterdam Pharma Co. N.V has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
NewAmsterdam Pharma Co. N.V has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for NewAmsterdam Pharma Co. N.V are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NAMS at this time, as NewAmsterdam Pharma Co. N.V has no recent EPS data to calculate it.
